Listed

ProPhase Labs, Inc.: Form 10-Q for the period ended Sep 30, 2016

Filed with the SEC on Nov 14, 2016 and accepted by EDGAR at Nov 15, 2016, 20:05 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2016-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2016-07-01 to 2016-09-30$5.2mus-gaap:SalesRevenueNet
Revenue9 months2016-01-01 to 2016-09-30$13.4mus-gaap:SalesRevenueNet
Cost of revenue3 months2016-07-01 to 2016-09-30$3.0mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue9 months2016-01-01 to 2016-09-30$7.2mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2016-07-01 to 2016-09-30$2.2mus-gaap:GrossProfit
Gross profit9 months2016-01-01 to 2016-09-30$6.2mus-gaap:GrossProfit
Research and development3 months2016-07-01 to 2016-09-30$119.0kus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2016-01-01 to 2016-09-30$374.0kus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2016-07-01 to 2016-09-30$220.0kus-gaap:OperatingIncomeLoss
Operating income9 months2016-01-01 to 2016-09-30−$2.1mus-gaap:OperatingIncomeLoss
Interest expense3 months2016-07-01 to 2016-09-30$53.0kus-gaap:InterestExpense
Interest expense9 months2016-01-01 to 2016-09-30$158.0kus-gaap:InterestExpense
Net income3 months2016-07-01 to 2016-09-30$167.0kus-gaap:NetIncomeLoss
Net income9 months2016-01-01 to 2016-09-30−$2.3mus-gaap:NetIncomeLoss
Diluted EPS3 months2016-07-01 to 2016-09-30$0.01us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2016-01-01 to 2016-09-30−$0.13us-gaap:EarningsPerShareDiluted
Basic EPS3 months2016-07-01 to 2016-09-30$0.01us-gaap:EarningsPerShareBasic
Basic EPS9 months2016-01-01 to 2016-09-30−$0.13us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2016-07-01 to 2016-09-3017,600 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2016-01-01 to 2016-09-3017,081 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2016-01-01 to 2016-09-30−$870.0kus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2016-01-01 to 2016-09-30$419.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2016-09-30$375.0kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2016-09-30$9.7mus-gaap:AssetsCurrent
Total assetsAt period end2016-09-30$12.8mus-gaap:Assets
Current liabilitiesAt period end2016-09-30$6.3mus-gaap:LiabilitiesCurrent
Shareholders' equityAt period end2016-09-30$6.5mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001493152-16-015094. Last ingested by Listed: Oct 24, 2026, 14:58 ET. Listed shows no prices and gives no investment advice.